Physician profile
Brenda K Baxter
NPI 1487898201
$245,760.77
in general payments reported to CMS, 2019-2025
26 companies · $96K in 2025
The $96K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,347 · 2022: $4,641 · 2023: $50K · 2024: $93K · 2025: $96K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $238K · Food and Beverage: $1,411 · Travel and Lodging: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $237,626.78 |
| Food and Beverage | $1,410.77 |
| Travel and Lodging | $735.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $177,009.63 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Insulet Corporation | $48,857.24 | 2021-2025 | Omnipod, Omnipod |
| Tandem Diabetes Care, INC. | $16,659.87 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $529.87 | 2021-2023 | Dexcom G7 Gss (161) |
| Novo Nordisk INC | $397.02 | 2021-2022 | |
| Beta Bionics, INC. | $388.56 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Lilly USA, LLC | $239.74 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $216.83 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $172.07 | 2021-2022 | |
| Mannkind Corporation | $160.97 | 2021 | |
| Sequel Med Tech, LLC | $130.03 | 2025 | Twiist |
| Abbvie INC. | $104.06 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $82.45 | 2021-2022 | |
| Grt US Holding, INC. | $82.21 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $73.92 | 2022 | |
| Lifescan, INC. | $66.27 | 2021-2022 | |
| Zealand Pharma US, INC. | $64.47 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $59.74 | 2021 | |
| Antares Pharma, INC. | $48.26 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $46.16 | 2022 | |
| Amneal Pharmaceuticals LLC | $42.24 | 2021-2022 | |
| Amryt Pharma Holdings Ltd | $42.11 | 2022 | |
| Merck Sharp & Dohme LLC | $21.25 | 2021 | |
| Glaxosmithkline, LLC. | $20.58 | 2023 | Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.